Suboptimal health: a new health dimension for translational medicine

Abstract Background One critical premise of disease‐related biomarkers is the definition of the counterpart normality. Contrary to pre‐clinical models that can be carefully tailored according to scientific need, heterogeneity and uncontrollability is the essence of humans in health studies. Fully ch...

Full description

Bibliographic Details
Main Authors: Wei Wang, Yuxiang Yan
Format: Article
Language:English
Published: Wiley 2012-12-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/2001-1326-1-28
id doaj-a0775e5283ea49d98f8afd222b0b4e7f
record_format Article
spelling doaj-a0775e5283ea49d98f8afd222b0b4e7f2020-11-25T02:50:37ZengWileyClinical and Translational Medicine2001-13262012-12-0111n/an/a10.1186/2001-1326-1-28Suboptimal health: a new health dimension for translational medicineWei Wang0Yuxiang Yan1School of Medical SciencesEdith Cowan UniversityPerthAustraliaBeijing Municipal Key Laboratory of Clinical Epidemiology and School of Public HealthCapital Medical UniversityBeijingChinaAbstract Background One critical premise of disease‐related biomarkers is the definition of the counterpart normality. Contrary to pre‐clinical models that can be carefully tailored according to scientific need, heterogeneity and uncontrollability is the essence of humans in health studies. Fully characterization of consistent parameters that define the normal population is the basis to individual differences normalization irrelevant to a given disease process. Self claimed normal status may not represent health because asymptomatic subjects may carry chronic diseases or diseases at their early stage such as cancer, diabetes and hypertension. Methods This paper exemplifies the characterization of the suboptimal health status (SHS) which represents a new public health problem in a population with ambiguous health complaints such as general weakness, unexplained medical syndrome and chronic fatigue. We applied clinical informatics approaches and developed a questionnaire for measuring SHS. The validity and reliability of this approach were evaluated in a small pilot study and then in a cross‐sectional study of 3,405 individuals. Results The final questionnaire congregated into a score (SHSQ‐25) which could significantly distinguish among several abnormal conditions. Conclusion SHSQ‐25 could be used as a translational medicine instrument for health measuring in the general population.https://doi.org/10.1186/2001-1326-1-28Suboptimal healthInstrument SHSQ‐25Chronic diseaseTranslational medicine
collection DOAJ
language English
format Article
sources DOAJ
author Wei Wang
Yuxiang Yan
spellingShingle Wei Wang
Yuxiang Yan
Suboptimal health: a new health dimension for translational medicine
Clinical and Translational Medicine
Suboptimal health
Instrument SHSQ‐25
Chronic disease
Translational medicine
author_facet Wei Wang
Yuxiang Yan
author_sort Wei Wang
title Suboptimal health: a new health dimension for translational medicine
title_short Suboptimal health: a new health dimension for translational medicine
title_full Suboptimal health: a new health dimension for translational medicine
title_fullStr Suboptimal health: a new health dimension for translational medicine
title_full_unstemmed Suboptimal health: a new health dimension for translational medicine
title_sort suboptimal health: a new health dimension for translational medicine
publisher Wiley
series Clinical and Translational Medicine
issn 2001-1326
publishDate 2012-12-01
description Abstract Background One critical premise of disease‐related biomarkers is the definition of the counterpart normality. Contrary to pre‐clinical models that can be carefully tailored according to scientific need, heterogeneity and uncontrollability is the essence of humans in health studies. Fully characterization of consistent parameters that define the normal population is the basis to individual differences normalization irrelevant to a given disease process. Self claimed normal status may not represent health because asymptomatic subjects may carry chronic diseases or diseases at their early stage such as cancer, diabetes and hypertension. Methods This paper exemplifies the characterization of the suboptimal health status (SHS) which represents a new public health problem in a population with ambiguous health complaints such as general weakness, unexplained medical syndrome and chronic fatigue. We applied clinical informatics approaches and developed a questionnaire for measuring SHS. The validity and reliability of this approach were evaluated in a small pilot study and then in a cross‐sectional study of 3,405 individuals. Results The final questionnaire congregated into a score (SHSQ‐25) which could significantly distinguish among several abnormal conditions. Conclusion SHSQ‐25 could be used as a translational medicine instrument for health measuring in the general population.
topic Suboptimal health
Instrument SHSQ‐25
Chronic disease
Translational medicine
url https://doi.org/10.1186/2001-1326-1-28
work_keys_str_mv AT weiwang suboptimalhealthanewhealthdimensionfortranslationalmedicine
AT yuxiangyan suboptimalhealthanewhealthdimensionfortranslationalmedicine
_version_ 1724737531004583936